| Heart disease and stroke statistics—2012 update: a report from the American Heart Association Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ... Circulation 125 (1), e2-e220, 2012 | 21124* | 2012 |
| European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other … Authors/Task Force Members:, J Perk, G De Backer, H Gohlke, I Graham, ... European heart journal 33 (13), 1635-1701, 2012 | 5888 | 2012 |
| Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future SE Kahn, ME Cooper, S Del Prato The Lancet 383 (9922), 1068-1083, 2014 | 1281 | 2014 |
| Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes V Lyssenko, R Lupi, P Marchetti, S Del Guerra, M Orho-Melander, ... The Journal of clinical investigation 117 (8), 2155-2163, 2007 | 891 | 2007 |
| Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. LC Groop, RC Bonadonna, S DelPrato, K Ratheiser, K Zyck, E Ferrannini, ... The Journal of clinical investigation 84 (1), 205-213, 1989 | 883 | 1989 |
| Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. LC Groop, RC Bonadonna, S DelPrato, K Ratheiser, K Zyck, E Ferrannini, ... The Journal of clinical investigation 84 (1), 205-213, 1989 | 883 | 1989 |
| Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. LC Groop, RC Bonadonna, S DelPrato, K Ratheiser, K Zyck, E Ferrannini, ... The Journal of clinical investigation 84 (1), 205-213, 1989 | 883 | 1989 |
| How do we define cure of diabetes? JB Buse, S Caprio, WT Cefalu, A Ceriello, S Del Prato, SE Inzucchi, ... Diabetes care 32 (11), 2133-2135, 2009 | 881 | 2009 |
| Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations F Rubino, DM Nathan, RH Eckel, PR Schauer, KGMM Alberti, PZ Zimmet, ... Obesity surgery 27 (1), 2-21, 2017 | 764 | 2017 |
| Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that β-cell death is caspase mediated, partially dependent … R Lupi, F Dotta, L Marselli, S Del Guerra, M Masini, C Santangelo, ... Diabetes 51 (5), 1437-1442, 2002 | 747 | 2002 |
| Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind … MA Nauck, S Del Prato, JJ Meier, S Durán-García, K Rohwedder, M Elze, ... Diabetes care 34 (9), 2015-2022, 2011 | 609 | 2011 |
| Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients F Dotta, S Censini, AGS van Halteren, L Marselli, M Masini, S Dionisi, ... Proceedings of the National Academy of Sciences 104 (12), 5115-5120, 2007 | 560 | 2007 |
| Management of type 2 diabetes: new and future developments in treatment AA Tahrani, CJ Bailey, S Del Prato, AH Barnett The Lancet 378 (9786), 182-197, 2011 | 550 | 2011 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino Sr, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 548 | 2018 |
| Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial P Home, P Bartley, D Russell-Jones, H Hanaire-Broutin, JE Heeg, ... Diabetes care 27 (5), 1081-1087, 2004 | 515* | 2004 |
| Functional and molecular defects of pancreatic islets in human type 2 diabetes S Del Guerra, R Lupi, L Marselli, M Masini, M Bugliani, S Sbrana, S Torri, ... Diabetes 54 (3), 727-735, 2005 | 500 | 2005 |
| The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia RA DeFronzo, JA Davidson, S Del Prato Diabetes, Obesity and Metabolism 14 (1), 5-14, 2012 | 483 | 2012 |
| Obesity and insulin resistance in humans: a dose-response study RC Bonadonna, G Leif, N Kraemer, E Ferrannini, S Del Prato, ... Metabolism 39 (5), 452-459, 1990 | 451 | 1990 |
| Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion C Ling, S Del Guerra, R Lupi, T Rönn, C Granhall, H Luthman, P Masiello, ... Diabetologia 51 (4), 615-622, 2008 | 438 | 2008 |
| Effect of linagliptin monotherapy on glycaemic control and markers of β‐cell function in patients with inadequately controlled type 2 diabetes: a randomized … S Del Prato, AH Barnett, H Huisman, D Neubacher, HJ Woerle, KA Dugi Diabetes, Obesity and Metabolism 13 (3), 258-267, 2011 | 404 | 2011 |
